Symptom severity assessment of allergic rhinitis: Part 1

Annals of Allergy, Asthma and Immunology

Volumn 91, Issue 2, 2003, Pages 105-114

  Spector, Sheldon L ^a   Nicklas, Richard A ^a   Chapman, Jean A ^a   Bernstein, I Leonard ^a   Berger, William E ^a   Blessing Moore, Joann ^a   Dykewicz, Mark S ^a   Fineman, Stanley M ^a   Lee, Rufus E ^a   Li, James T ^a   Portnoy, Jay M ^a   Schuller, Diane E ^a   Lang, David ^a   Tilles, Stephen A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; HERBACEOUS AGENT; LEUKOTRIENE;

ALLERGIC RHINITIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EDEMA; HUMAN; LACRIMATION; NASAL PRURITUS; NOSE CONGESTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RHINITIS; RHINORRHEA; SNEEZING; SYMPTOMATOLOGY; TREATMENT PLANNING; VISUAL ANALOG SCALE;

EID: 0042238069     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62160-6     Document Type: Article

References (14)

1. Diagnosis and management of rhinitis: parameter documents of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1998;81: S463-S518.
2. Miller GA. The magical number seven, plus or minus two: some limits on our capacity for processing information. Psychol Rev. 1956;63:81-97.
3. Pemberton EA. Technique for measuring the optimum rating scale for opinion measures. Sociol Soc Res. 1933;17:470-472.
4. Juniper EF, Guyatt GH, Andersson B, Ferrie PJ. Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Ann Allergy. 1993;70:225-230.
5. Bagenstose SE, Bernstein JA. Treatment of chronic rhinitis by an allergy specialist improves quality of life outcomes. Ann Allergy Asthma Immunol. 1999;8:524-528.
6. Berdeaux G, Hervie C, Smajda C, Marquis P. Parental quality of life and recurrent ENT infections in their children: development of a questionnaire. Rhinitis Survey Group. Qual Life Res. 1998; 7:501-512.
7. Juniper EF, Thompson AD, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol. 1999;104: 364-369.
8. Burkstein DA, McGrath MM, Buchner DA, Landgraf J, Goss TF. Evaluation of a short form for measuring health-related quality of life among pediatric asthma patients. J Allergy Clin Immunol. 2000;105:245-251.
9. Juniper EF. Measuring health related quality of life in rhinitis. J Allergy Clin Immunol. 1997;2:S742-S749.
10. Juniper EF, Howland WD, Roberts NB, Thompson AK, King DR. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol. 1998;101:163-170.
11. Scadding GK. Rhinitis medicamentosa. Clin Exp Allergy. 1995; 23:391-394.
12. Graf P, Hallen H. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. Laryngoscope. 1996;106:605-609.
13. Wilson AM, Orr LC, Sims EJ, Lipworth BJ. Effects of monotherapy with intranasal corticosteroid or combined oral antihistamines and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy. 2001;31:61-68.
14. Greiff L, Andersson M, Svensson C, et al. Effects of orally inhaled budesonide in seasonal allergic rhinitis. Eur Respir J. 1998;11:1268-1273.